CML-384 Immunological Response to SARS-CoV-2 After Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients – A Prospective Study

Context: Patients with hematologic malignancies have an increased risk of SARS-CoV-2 infection, severe COVID-19, and higher mortality rates. Objective: We investigated the immunological response to SARS-CoV-2 after infection and/or vaccination and explored the impact of treatment response on antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvis, Marisol Miranda, Bradshaw, Danielle, Farmaha, Jaspreet, Jones, Kimya, Singh, Harmanpreet, Vashisht, Ashutosh, Sahajpal, Nikhil, Kolhe, Ravindra, Cortes, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Chronic Myeloid Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489252/
http://dx.doi.org/10.1016/S2152-2650(22)01378-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489252/
http://dx.doi.org/10.1016/S2152-2650(22)01378-7

Ejemplares similares